QBiotics' diverse product pipeline

QBiotics specialises in the discovery and development of plant-derived, cell signalling small molecules. Our current focus is the treatment of solid tumours and chronic wounds, with other programmes, such as antibiotics, at early discovery phase ready to be brought into development once our current programmes are commercialised.  Validated by rigorous clinical trial programmes, our products meet the high efficacy and safety standards demanded by international regulatory authorities.  We co-development our human and veterinary products as ‘real world’ data from veterinary programmes informs and de-risks our human drug development.  In addition, veterinary products are quicker to market providing early and repeatable revenue streams.

Advanced candidates: focus is on oncology and wound healing

Pipeline.jpg